Elevated levels of sCD40L have been observed in subgroups of RA patients [12], correlating with disease activity and the presence of autoantibodies such as anti-cyclic citrullinated peptide antibodies (ACPA) and rheumatoid factor (RF) [13]. Here, PRTN3 is linked to rheumatoid arthritis.